Covid Vaccine Glass Tubing Manufacturer Schott Invests 70 Million Euros In A Facility In Gujarat
SCHOTT Glass India, a leading German speciality glass manufacturer, has announced a 70 million euro investment to expand its Gujarat tubing factory, which currently produces FIOLAX glass, which is used in Covid-19 vaccine packaging in India.
SCHOTT’s glass tubing is used to package about 95% of Covid-19 vaccinations in India, according to the business. SCHOTT’s glass tubing is manufactured in Jambusar, Gujarat. Following the visit to the facility by German Ambassador to India Walter J Lindner, SCHOTT Glass India’s Managing Director Pawan Shukla confirmed the company’s statement of a new investment of 70 million euros, following several million in previous years.
Gujarat’s tubing facility is Asia’s leading producer of high-quality pharma glass tubing. It has also been a leader in the fight against Covid-19, providing pharmaceutical glass for primary packaging that has been used to fill billions of Covid-19 vaccinations across the world. SCHOTT’s FIOLAX glass, which has been the gold standard for pharmaceutical packaging for more than a century, is used to package practically all licensed vaccines in India.
The material is most suited for vaccinations and life-saving pharmaceuticals, according to SCHOTT, since it minimizes interactions between containers and drug formulations that might impair their efficiency.